DUSA Profile
DUSA Pharmaceuticals Inc. (DUSA) was a pharmaceutical company that focused on the development and commercialization of dermatology products for the treatment of various skin conditions, including actinic keratosis and acne. The company was acquired by Sun Pharmaceutical Industries in 2012 and is no longer publicly traded.
As of its last market close, DUSA was not actively traded on any major stock exchange and is no longer a publicly traded company. Therefore, there is no current market capitalization or stock price information available for DUSA.
Investing in DUSA is no longer possible, as the company was acquired and is no longer publicly traded. Investors interested in the pharmaceutical industry may consider other publicly traded companies in the sector. However, any investment carries risks, including risks associated with fluctuations in the stock market and the performance of the underlying assets. Investors should carefully consider these risks before making any investment decisions.
|
